Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, ottobre 26
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
LifeStance Health Group Inc
LFST
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$13.09
0.16
1.2%
Ult. Agg.: Oct 26, 1:33 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 10 giorni da adesso in gio nov 5th, prima dell'apertura del mercato
LifeStance Health Gr Financials
LifeStance Health Gr (LFST) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
LifeStance Health Gr Sees Q3 Sales $420.000M-$440.000M vs $418.474M Est
LifeStance Health Gr (NASDAQ:LFST) sees Q3 sales of $420.000 million-$440.000 million vs $418.474 million analyst estimate.
Benzinga Newsdesk
PRO
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.640B-$1.680B to $1.685B-$1.725B vs $1.665B Est
LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.640 billion-$1.680 billion to $1.685 billion-$1.725 billion vs $1.665 billion estimate.
Benzinga Newsdesk
PRO
LifeStance Health Gr Q2 EPS $0.06 Beats $0.04 Estimate, Sales $435.354M Beat $414.577M Estimate
LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 700 percent increase over losses of $(0.01) per share from
Benzinga Newsdesk
PRO
LifeStance Health Gr Sees Q2 Sales $405.000M-$425.000M vs $401.519M Est
LifeStance Health Gr (NASDAQ:LFST) sees Q2 sales of $405.000 million-$425.000 million vs $401.519 million analyst estimate.
Benzinga Newsdesk
PRO
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.615B-$1.655B to $1.640B-$1.680B vs $1.636B Est
LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.615 billion-$1.655 billion to $1.640 billion-$1.680 billion vs $1.636 billion estimate.
Benzinga Newsdesk
PRO
LifeStance Health Gr Q1 EPS $0.04 Beats $0.01 Estimate, Sales $403.476M Beat $387.367M Estimate
LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 percent. The company reported quarterly sales of $403.476 million which beat
Benzinga Newsdesk
